Cancer Diagnostics system is developed by Biomarker Strategies (BMS) that is used for predictive tests to treatment selection for patients with solid tumor malignancies. With this system, you can determine pharmacodynamic changes in the solid tumors of individual patients. If you want to know about CDx for solid tumors.